|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
Biomarker |
BEFREE |
Among 52 participants whose human leukocyte antigen typing was carried out, all of the participants with slowly progressive insulin-dependent diabetes mellitus who had DRB1*09:01 were positive by GADA-ELISA (P = 0.021).
|
31267698 |
2020 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
Analysis of HLA-DRB1 genotypes revealed locus-level T1D association (p = 6.0E-05); DRB1*04:01 appeared predisposing (p < 3.0E-06), and DRB1*14:01 appeared protective (p = 1.7E-02).
|
31669629 |
2019 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
Differences were also noted between AP and T1D pertaining to the DRB1 allele (p<0.041).
|
31675055 |
2019 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
Biomarker |
BEFREE |
Compared to DRB1*03, HLA-DRB1*04 was associated with higher T1DM incidence.
|
30428494 |
2019 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
Biomarker |
BEFREE |
A strong positive association of DRB1*04-DQA1*0301-DQBl*0302 (OR=5.67, p<0.001) and DRB1*0301-DQA1*0501-DQB1*0201 (OR=6.24, p<0.001) putative haplotypes with IDDM was evident in Jordanian IDDM patients whereas DRB1*1101-DQA1*0505- DQB1*0301 (OR=0.23, p=0.03) was shown to have a protective role against T1D in Jordanians.
|
31742498 |
2019 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
Biomarker |
BEFREE |
Our study indicates that DRB1*03 (OR = 2.86), DRB1*04 (OR = 2.78), and DQB1*02 (OR = 2.29), are positively associated with increased risk of T1DM, while DRB1*07 (OR = 0.48), DRB1*11 (OR = 0.20), DRB1*13 (OR = 0.47), DRB1*15 (OR = 0.30), DQB1*05 (OR = 0.39), and DQB1*06 (OR = 0.27) were negatively associated with T1D, suggesting a protective role against T1D.
|
30004835 |
2019 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
Next-generation targeted sequencing of HLA-DRB1 and HLA-DRB3, -DRB4, and -DRB5 (abbreviated as DRB345) provides high resolution of functional variant positions to investigate their associations with type 1 diabetes risk and with autoantibodies against insulin (IAA), GAD65 (GADA), IA-2 (IA-2A), and ZnT8 (ZnT8A).
|
31127057 |
2019 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
Biomarker |
BEFREE |
In T1D patients, the allele DRB1*03:01 demonstrated highly significant T1D association (p < 10<sup>-16</sup>), with no apparent risk conferred by DRB1*04:xx alleles.
|
30710658 |
2019 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
We generated a novel HLA-transgenic mouse model that expresses high-risk genes for type 1 diabetes (DRB1*03:01-DQA1*05:01-DQB1*02:01) as well as human CD80 under the rat insulin promoter and human CD4, on a C57BL/6 background.
|
31612266 |
2019 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
Carriers of pathogenic variants had HLA-DRB1 risk alleles for autoimmune diabetes and clinical characteristics compatible with type 1 diabetes except for the absence of autoimmunity.
|
31365591 |
2019 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
Furthermore, relatives with single islet AAb (by traditional assays) and carrying both IA-2var AAb and the high-risk HLA-DRB1*04-DQB1*03:02 haplotype progress rapidly to onset of T1D.
|
31167877 |
2019 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
Biomarker |
BEFREE |
Negative associations were found between T1D and DRB1*07, *11, *13, and *15 (13.8% vs 26.1% in controls [P<sub>c</sub> = 0.00175], 3.9% vs 16.9% in controls [P<sub>c</sub> = 6.55× 10<sup>-6</sup> ], 5.5% vs 21.6% in controls [P<sub>c</sub> = 2.51 × 10<sup>-7</sup> ], and 16.9% vs 43.9% in controls [P<sub>c</sub> = 9.94× 10<sup>-10</sup> ], respectively).
|
30614662 |
2019 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
In addition to clarifying the roles of several known T1D HLA alleles and haplotypes, we discovered that the DRB1*08:03-DQB1*06:01 haplotype is protective against T1D.
|
29383806 |
2018 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
Biomarker |
BEFREE |
The -1123G > C SNP in the PTPN22 gene promoter and HLA DRB1*0405-DQB1*0401 might influence the concurrence of systemic and organ-specific ADs in patients with type 1 diabetes.
|
29762907 |
2018 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
Biomarker |
BEFREE |
DRB1*04:01-restricted responses toward many of these peptides have been previously described, but responses to a novel pre-proinsulin 9-28 peptide were commonly observed in subjects with T1D.
|
30455401 |
2018 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
The higher frequency of HLA-DRB1*03/DRB1*03 among APS3v patients was the only significant difference in genotype frequency when compared to T1D patients, while high risk (HLA-DRB1*03/DRB1*04) and medium risk genotypes for T1D (HLA-DRB1*04/DRB1*04) occurred with similar frequencies in both patient groups.
|
29958949 |
2018 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
Biomarker |
BEFREE |
Combined effect of glutamine at position 70 of HLA-DRB1 and alanine at position 57 of HLA-DQB1 in type 1 diabetes: An epitope analysis.
|
29494662 |
2018 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
Associations of CTLA4 +49 A/G Dimorphism and HLA-DRB1*/DQB1* Alleles With Type 1 Diabetes from South India.
|
29603038 |
2018 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
Human leukocyte antigen typing showed haplotype DRB1*09:01-DQB1*03:03, which was reported to be closely associated with type 1 diabetes mellitus in Japan.
|
29343652 |
2018 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
By examining the epigenetic methylation maps of cord blood samples, we found marked differences in the methylation status of CpG sites within the MHC genes (cis-metQTLs) between carriers of the type 1 diabetes risk haplotypes HLA-DRB1*03-DQA1*0501-DQB1*0201 (DR3-DQ2) and HLA-DRB1*04-DQA1*0301-DQB1*0302 (DR4-DQ8).
|
29224923 |
2018 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
Biomarker |
BEFREE |
The patient had both type 1 diabetes susceptible (HLA-A*24:02 and -DRB1*09:01) and resistant (HLA-DRB1*15:02) HLA genotypes.
|
28418115 |
2018 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
HLA Class II genotyping revealed DRB1-DQB1*0901-*0303, a common susceptibility haplotype in Japanese patients with type 3 APS or acute-onset type 1 diabetes.
|
29459556 |
2018 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
Biomarker |
BEFREE |
Epidemiology of childhood-onset type 1 diabetes in Azerbaijan: Incidence, clinical features, biochemistry, and HLA-DRB1 status.
|
30218742 |
2018 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
HLA-B (n=395), HLA-DRB1 (n=501) and HLA-DQB1 (n=475) alleles were genotyped in pregnant women (mothers of children who later developed type 1 diabetes and mothers of non-diabetic children).
|
27623983 |
2017 |
|
HLA-DRB1
|
Diabetes Mellitus, Insulin-Dependent
|
0.500 |
GeneticVariation |
BEFREE |
In Somali children with T1D aged 13.5 ± 5 yr (35% female, disease duration 6.5 ± 3.6 yr), the most common HLA allele was DRB1*03:01 (93%, compared with 45% of Somali controls), followed by DRB1*13:02 (27%).
|
26854192 |
2017 |